A detailed history of Global Retirement Partners, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 72 shares of MDGL stock, worth $24,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72
Previous 79 8.86%
Holding current value
$24,351
Previous $22,000 31.82%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$212.22 - $292.96 $1,485 - $2,050
-7 Reduced 8.86%
72 $15,000
Q2 2024

Jul 23, 2024

BUY
$193.33 - $291.99 $11,019 - $16,643
57 Added 259.09%
79 $22,000
Q1 2024

Apr 23, 2024

SELL
$171.37 - $283.23 $17,137 - $28,323
-100 Reduced 81.97%
22 $5,000
Q4 2023

Jan 18, 2024

BUY
$120.4 - $237.13 $12,040 - $23,713
100 Added 454.55%
122 $28,000
Q1 2023

May 05, 2023

BUY
$231.06 - $307.08 $5,083 - $6,755
22 New
22 $5,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.78B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.